Aflac (AFL) Misses Q4 EPS
Tweet
Share
E-mail
Get Alerts AFL Hot Sheet
Price: $115.67 -1.31%
Revenue Growth %: -14.1%
Financial Fact:
Amortization of deferred policy acquisition costs: 282M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -14.1%
Financial Fact:
Amortization of deferred policy acquisition costs: 282M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Aflac (NYSE: AFL) reported Q4 EPS of $1.54 vs analyst estimate of $1.63. Revenue for the quarter came in at $6 billion versus the consensus estimate of $5.65 billion.
For earnings history and earnings-related data on Aflac (AFL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- ASP Isotopes holds first capital markets day, targets $300M EBITDA by 2031
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
